Cargando…

Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial

AIM: The prospective, noninterventional OCEAN study assessed the safety of intravitreal ranibizumab injections for treatment of neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion under real-world conditions in Germany. METHODS: Adults receiving ≥1 ranibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziemssen, Focke, Hammer, Thomas, Grueb, Matthias, Mueller, Bettina, Berk, Hüsnü, Gamulescu, Maria-Andreea, Voegeler, Jessica, Wachtlin, Joachim, OCEAN Study Group
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558801/ https://www.ncbi.nlm.nih.gov/pubmed/33083052 http://dx.doi.org/10.1155/2020/8652370

Ejemplares similares

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
por: Wachtlin, Joachim, et al.
Publicado: (2020)

Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany
por: Ziemssen, Focke, et al.
Publicado: (2018)

Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
por: Sobolewska, Bianka, et al.
Publicado: (2021)

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
por: Strunz, Tobias, et al.
Publicado: (2022)

pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017)

Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
por: Ma, Pan, et al.
Publicado: (2022)

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol
por: Vormfelde, Stefan Viktor, et al.
Publicado: (2016)

Adhärenz bei der Anti-VEGF-Therapie – Überlegungen und praktische Empfehlungen
por: Lommatzsch, Albrecht, et al.
Publicado: (2020)

Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA
por: Ziemssen, Tjalf, et al.
Publicado: (2020)

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
por: Dimopoulos, Spyridon, et al.
Publicado: (2015)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
por: Barth, T., et al.
Publicado: (2019)

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study
por: Bergmann, Lothar, et al.
Publicado: (2015)

ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
por: Liakopoulos, Sandra, et al.
Publicado: (2020)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
por: Sullivan, John T.
Publicado: (2022)

Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders: A noninterventional study with Iberogast®
por: Raedsch, Richard, et al.
Publicado: (2017)

Continuous Digital Monitoring of Walking Speed in Frail Elderly Patients: Noninterventional Validation Study and Longitudinal Clinical Trial
por: Mueller, Arne, et al.
Publicado: (2019)

Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis
por: Mäurer, Mathias, et al.
Publicado: (2019)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

Pill Burden in Patients With Type 2 Diabetes in Germany: Subanalysis From the Prospective, Noninterventional PROVIL Study
por: Blüher, Matthias, et al.
Publicado: (2015)

Anti-VEGF-Therapie bei fibrovaskulärer und serös-vaskularisierter Pigmentepithelabhebung bei neovaskulärer AMD: Eine retrospektive Fünf-Jahres-Analyse
por: Barth, T., et al.
Publicado: (2020)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax
por: Nikolić, Marko Z., et al.
Publicado: (2015)

Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study
por: Lass-Flörl, Cornelia, et al.
Publicado: (2020)

Acute Pancreatitis in Pregnancy: A Ten-Year Noninterventional, Retrospective Cohort Experience
por: Haiyan, Zhao, et al.
Publicado: (2022)

Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis
por: Butler, Anne M., et al.
Publicado: (2023)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment
por: Enders, Christian, et al.
Publicado: (2022)

Interdisziplinäre Kommunikation: Augenarztbriefe an diabetologische Schwerpunktpraxen (DSP)
por: Stock, Lydia, et al.
Publicado: (2020)

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

076 Risk of severe COVID-19 associated with immune-modifying drugs: data from PsoProtect and Global Rheumatology Alliance registries
por: Group, P Study, et al.
Publicado: (2022)

Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD
por: Gamulescu, Maria-Andreea, et al.
Publicado: (2012)

Morphology of foveal hypoplasia: Hyporeflective zones in the Henle fiber layer of eyes with high-grade foveal hypoplasia
por: Bringmann, Andreas, et al.
Publicado: (2022)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
por: Scicchitano, Francesca, et al.
Publicado: (2012)

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
por: Giofrè, Chiara, et al.
Publicado: (2013)

Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing
por: Schmider, Juergen, et al.
Publicado: (2018)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

Dictionary of pharmacovigilance /
por: Alghabban, Amer
Publicado: (2004)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0uevdbjqh2ul6uujdn7gd06sc4